Background illustration for clinical trials search

Paid Clinical Trials Plano

Discover 1,928 paid clinical trials in Plano, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma

for
Vestibular Schwannoma
Location: Dallas TX, Nashville TN, Rochester MN, Baltimore MD
Sponsor: Akouos, Inc.

Sex: All

Age: 18+

Code: NCT06517888

Phase1, Phase2, Recruiting
Active & Responsive

A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

for
Colorectal Cancer
Location: Dallas TX, Shreveport LA, Houston TX, The Woodlands TX,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06562543

Recruiting
Active & Responsive

Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing

for
Drug Allergy, Cephalosporin Allergy, Drug Hypersensitivity,
Location: Dallas TX, Nashville TN, Scottsdale AZ, Rochester NY,
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18 - 70

Code: NCT06406114

Phase2, Recruiting
Active & Responsive

PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

for
Progressive Pulmonary Fibrosis, Interstitial Lung Disease
Location: Dallas TX, Ann Arbor MI, Charlottesville VA,
Sponsor: University of Massachusetts, Worcester

Sex: All

Age: 18 - 70+

Code: NCT06855329

Recruiting
Active & Responsive

A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old

for
Graves' Disease
Location: Dallas TX, Asheville NC, Glendale AZ, Miami FL,
Sponsor: Biogen

Sex: All

Age: 18 - 70+

Code: NCT07722546

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

for
Type 1 Diabetes Mellitus, T1D, T1DM,
Location: Dallas TX, Waxahachie TX, Austin TX, Humble TX,
Sponsor: COUR Pharmaceutical Development Company, Inc.

Sex: All

Age: 12 - 35

Code: NCT06783309

Phase1, Phase2, Recruiting
Active & Responsive

Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders

for
Langerhan's Cell Histiocytosis, Juvenile Xanthogranuloma,
Location: Dallas TX, Houston TX, Little Rock AR, Phoenix AZ,
Sponsor: Carl Allen

Sex: All

Age: 0+

Code: NCT04079179

Phase2, Recruiting
Active & Responsive

A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment

for
Alagille Syndrome
Location: Dallas TX, Memphis TN, Kansas City MO, St Louis MO,
Sponsor: Ipsen

Sex: All

Age: 0+

Code: NCT06850038

Recruiting
Active & Responsive

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC)

for
Niemann-Pick Type C Disease
Location: Dallas TX, Rochester MN, Minneapolis MN, Fairfax VA,
Sponsor: Azafaros B.V.

Sex: All

Age: 4+

Code: NCT07082725

Phase3, Recruiting
Active & Responsive

Pediatric Post-Approval Registry

for
Obstructive Sleep Apnea
Location: Dallas TX, Aurora CO, Cincinnati OH, Durham NC,
Sponsor: Inspire Medical Systems, Inc.

Sex: All

Age: 18 - 21

Code: NCT04457154

Recruiting
Active & Responsive

Transitional Intervention for Hyperacusis in Autism

for
Loudness Hyperacusis, Autism Spectrum Disorder (ASD),
Location: Dallas TX
Sponsor: University of Central Florida

Sex: All

Age: 18 - 39

Code: NCT07798297

Recruiting
Active & Responsive

A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1

for
HIV-1-infection
Location: Dallas TX, Longview TX, Austin TX, Houston TX,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT07645287

Phase2, Recruiting
Active & Responsive

Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)

for
Breast Neoplasms, Breast Cancer
Location: Dallas TX, Houston TX, Nashville TN, Skokie IL,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06797635

Phase2, Recruiting
Active & Responsive

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

for
Solid Tumors
Location: Dallas TX, Grapevine TX, Bedford TX, Wichita KS,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT07415031

Phase2, Recruiting
Active & Responsive

A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies

for
Chronic Lymphocytic Leukemia, B-cell Malignancies
Location: Dallas TX, Rochester MN, Columbus OH, Pittsburgh PA,
Sponsor: Curis, Inc.

Sex: All

Age: 18+

Code: NCT07271667

Phase2, Recruiting
Active & Responsive

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer,
Location: Dallas TX, Fort Worth TX, Houston TX, Westwood KS,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT06901531

Phase3, Recruiting
Active & Responsive

A Study of Mirikizumab Solution (LY3074828) in Healthy Participants

for
Healthy
Location: Dallas TX, San Antonio TX, Madison WI, Dilworth MN,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 65

Code: NCT07446101

Phase1, Recruiting
Active & Responsive

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

for
Intestinal Neoplasms, Gastrointestinal Neoplasms,
Location: Irving TX, Flower Mound TX, Denton TX, Denison TX,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07222800

Phase3, Recruiting
Active & Responsive

Phase 2 Study to Assess the Safety and Efficacy of ANG003

for
Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)
Location: Dallas TX, Kansas City KS, Denver CO, Lexington KY,
Sponsor: Anagram Therapeutics, Inc.

Sex: All

Age: 12+

Code: NCT07450547

Phase2, Recruiting
Active & Responsive

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

for
Generalized Myasthenia Gravis
Location: Dallas TX, Houston TX, Columbia MO, Birmingham AL,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT04202341

Recruiting